RP-HPLC determination of paraoxonase 3 activity in human blood serum

Journal of Pharmaceutical and Biomedical Analysis

Volumn 42, Issue 1, 2006, Pages 113-119

  Suchocka, Zofia ^a   Swatowska, Joanna ^a   Pachecka, Jan ^a   Suchocki, Piotr ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

HDL antioxidative enzymes; Paraoxonase 3; PON3; Statinase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; PARAOXONASE 3; SIMVASTATIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME SUBSTRATE; HUMAN; INCUBATION TIME; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPECTRAL SENSITIVITY; ULTRAVIOLET SPECTROSCOPY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTERASES; HUMANS; SIMVASTATIN; TIME FACTORS;

EID: 33747809600     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.02.015     Document Type: Article

References (28)

1. Ng C.J., Shih D.M., Hama S.Y., Villa N., Navab M., and Reddy S.T. Free Radic. Biol. Med. 38 (2005) 153-163
2. Reddy S.T., Wadleigh D.J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D.M., Lusis A.J., Navab M., and Fogelman Al.M. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 542-547
3. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., and La Du B.N. J. Biol. Chem. 275 (2000) 33435-33442
4. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., and La Du B.N. J. Lipid Res. 46 (2005) 1239-1247
5. Billecke S., Draganov D., Counsell R., Stetson P., Watson C., Hsu C., and La Du B.N. DMD 28 (2000) 1335-1342
6. Draganov D.I., and La Du B.N. Pharmacogen. Naunyn Schmiedebergs Arch. Pharmacol. 369 (2004) 78-88
7. Vickers S., Duncan C.A., Chen I.W., Rosegay A., and Duggan D.E. DMD 8 (1990) 138-145
8. Rosati E., Aracri N., Bottone A., Cau C., and Scotti E. Minerva Cardioangiol. 50 (2002) 63-68
9. Werner M., and Sacher J.M. Br. J. Pharmacol. 143 (2004) 715-724
10. Gryglewski R.J., Uracz W., Swies J., Chlopicki S., Marcinkiewicz E., Lomnicka M., and Madej J. Ann. NY Acad. Sci. 947 (2001) 229-245
11. Van Vliet A.K., Negre-Aminou P., van Thiel G.C.F., Bolhuis P.A., and Cohen L.H. Biochem. Pharmacol. 52 (1996) 1387-1392
12. Negre-Aminou P., van Erck M., van Leeuwen R.E., and Collard J.G. Biochem. Pharmacol. 61 (2001) 991-998
13. Mueck A.O., Seeger H., and Wallwiener D. Menopause 10 (2003) 332-336
14. Chen C., Mireles R.J., Campbell S.D., Lin J., Mills J.B., Xu J.J., and Smolarek T.A. DMD 33 (2005) 537-546
15. Prueksaritanont T., Qiu Y., Mu L., Michel K., Brunner J., Richards K.M., and Lin J.H. Pharm. Res. 22 (2005) 1101-1109
16. Srinivasu M.K., Raju A.N., and Reddy G.O. J. Pharm. Biomed. Anal. 29 (2002) 715-721
17. Ochiai H., Uchiyama N., Imagaki K., Hata S., and Kamei T. J. Chromtogr. B 694 (1997) 211-217
18. Miao X.-S., and Metcalfe C.D. J. Chromtogr. A 998 (2003) 133-141
19. Yang H., Feng Y., and Luan Y. J. Chromtogr. B 785 (2003) 369-375
20. Zhang N., Yang A., Rogers J.D., and Zhao J.J. J. Pharm. Biomed. Anal. 34 (2004) 175-187
21. Carlucci G., Mazzeo P., Biordi L., and Bologna M. J. Pharm. Biomed. Anal. 10 (1992) 693-697
22. European Pharmacopoeia, Supl. (2001) 1403-1405.
23. Godoy R., Godoy C.G., De Diego M., and Gómez C. Chil. Chem. Soc. 49 (2004) 289
24. Kaufman M.J. Pharm. Res. 7 (1990) 289-292
25. Javernik S., Kreft S., and Strukelj B.F. Pharmazie 56 (2001) 738-740
26. Javernik S.R., Kreft S., and Borut T. V. Franc. Croat. Chem. Acta 76 (2003) 263-268
27. Braggio S., Grossi R.J.P., and Cugola M.A. J. Pharm. Biomed. Anal. 14 (1996) 375-388
28. Prueksaritanont T., Zhao J.J., Ma J.J.B., Roadcap B.A., Tang C., Qiu Y., Liu L., Lin J.H., Pearson P.G., and Baillie T.A. J. Pharmacol. Exp. Ther. 301 (2002) 1042-1051